Ennaid Therapeutics | Bringing Cures That Sustain Abundant Life
home,page,page-id-15847,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-,vc_responsive
400+ Million Infections

Zika virus, a mosquito-borne virus that is explosively spreading, 4 million infections expected in 2016, causes microcephaly birth defects. Dengue virus, a life-debilitating, potentially deadly mosquito-borne virus that infects 400 million people, hospitalizes 1.5 million and kills 100,000+ annually

We Have A Cure

Ennaid Therapeutics is using its unique platform technology of flavivirus inhibitors to develop cures for Zika Virus & all four strains of Dengue virus.

Strategic Partnerships

We welcome strategic partnerships, as partnerships accelerate the development of our cures from the lab to the people who need them.

Our Mission

Bringing Cures That Sustain Abundant Life

lab bench
Ennaid Drug Development

Developing the world’s first therapeutic for Zika virus & all four strains of Dengue virus

Ennaid Healthcare IT

Developing Computer Vision/ Eye tracking software for use in healthcare applications

Ennaid is Dianne (the CEO’s and president’s Mother’s name,) spelled backwards.

Dianne means divine/heavenly! Therapeutics means healing solutions.

Ennaid Therapeutics = Divine Healing Solutions

Ennaid Therapeutics affirms the unending presence of healing power and recognizes our path of responsibility as the world’s foremost leader in the sustaining of abundant life. We dispel the impossible by bringing innovative cures to rare and seemingly incurable diseases, thus improving the health and saving the lives of patients all over the world.


Our team of experts


Darnisha Grant Harrison

CEO and President


Ron Aube Ph.D

VP, International Business Development


Romeo Ibrahim

Scientific Advisory Board


Robert Garry, Ph.D

Chief Scientific Officer, Inventor & Board of Directors

Meet The Rest Of Our Superb Team

Message From Our CEO


Darnisha Grant Harrison

President & CEO

“At Ennaid Therapeutics, we recognize the vast amount of good science sitting on research shelves waiting to be positively exploited for use in humans and animals. Therefore, we are committed to translating complex science into today’s cures to help patients live healthier, more abundant lives. We have made great strides as a company and have a promising technology, an accelerated plan and an expert team to develop and commercialize ca cure for Dengue virus..”

We have the technology, the plan and the team to develop & commercialize cures
for Zika Virus and Dengue Virus.

Join Us As We Race To The Cure. Become A Strategic Partner Today!